An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206856
Company: NOVITIUM PHARMA

Products on ANDA 206856

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TRANYLCYPROMINE SULFATE	TRANYLCYPROMINE SULFATE	EQ 10MG BASE	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 206856

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/17/2018	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 206856

TRANYLCYPROMINE SULFATE

TABLET;ORAL; EQ 10MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
PARNATE	TRANYLCYPROMINE SULFATE	EQ 10MG BASE	TABLET;ORAL	Prescription	Yes	AB	012342	CONCORDIA
TRANYLCYPROMINE SULFATE	TRANYLCYPROMINE SULFATE	EQ 10MG BASE	TABLET;ORAL	Prescription	No	AB	213503	CROSSMEDIKA SA
TRANYLCYPROMINE SULFATE	TRANYLCYPROMINE SULFATE	EQ 10MG BASE	TABLET;ORAL	Prescription	No	AB	206856	NOVITIUM PHARMA
TRANYLCYPROMINE SULFATE	TRANYLCYPROMINE SULFATE	EQ 10MG BASE	TABLET;ORAL	Prescription	No	AB	040640	STRIDES PHARMA

Top